Clinical Trial

Olive Leaf Extract, Meta-inflammation, Anxiety, and Excess Weight

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 18, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Excess Weight is accompanied by a process that produces a low-grade inflammation state, called meta-inflammation. Anxiety is also associated with inflammation. Inflammation is closely related to oxidative stress. Both processes help perpetuate each other. Olive Leaf Extract (OLE) is known for having anti-inflammatory and antioxidant effects; by this means, its anxiolytic effect has been proved in animal models. The purpose of this investigation is to evaluate the anti-inflammatory and anxiolytic effects associated with the supplementation of OLE at a daily dose of 750mg (20% oleuropein) for 3 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-28.
Trial Details
NCT Number NCT06485349
Lead Sponsor University of Guadalajara
Conditions Women, Excess Weight, Anxiety Disorders
Enrollment 70 participants
Start Date 2024-10-16
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-18